• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on brain metabolic enzyme involved in the formation of neurotoxic pyridinium metabolite derived from antipsychotic agent

Research Project

Project/Area Number 10672115
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Environmental pharmacy
Research InstitutionKOBE GAKUIN UNIVERSITY

Principal Investigator

IGARASHI Kazuo  KOBE GAKUIN UNIVERSITY, Faculty of Pharmaceutical Sciences, Associate Professor, 薬学部, 助教授 (80098467)

Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 1999: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1998: ¥1,900,000 (Direct Cost: ¥1,900,000)
KeywordsHaloperidol / Neurotoxicity / Pyridinium metabolite / P450 / Peroxidase / Brain enzyme / 脳内酵素系 / 脳内代謝
Research Abstract

This study was undertaken to examine the metabolic enzyme system in brain involved in the formation neurotoxic pyridinium metabolite (HPPィイD1+ィエD1) derived from antipsychotic agent haloperiodol (HP). In vitro oxidations of HP and its dehydrated product HPTP to HPPィイD1+ィエD1 were investigated using various brain preparations. The mitochondorial fraction proved to be most active. Although HPTP appeared to be a better substrate than HP in rat brain, its conversion to HPPィイD1+ィエD1 was not NADPH dependent suggesting that it is not catalyzed by cytochrome P450. In addition, we attempted inhibition experiments using the MAO inhibitors clorgyline and deprenyl. Moderate and concentration dependent inhibition was observed with clorgyline (an MAO-A selective inhibitor). This result suggests that brain MAO-A may contribute to HPPィイD1+ィエD1 formation from HPTP. In order to examine the possibility of peroxide-supported P450 catalysis of HP to HPPィイD1+ィエD1, we conducted incubations using cumene hydroperoxide (CuOOH). The conversion of HP to HPPィイD1+ィエD1 increased by about 3 times in the presence of CuOOH. Moreover, the study using enzyme preparations of horseradish peroxidase or myeroperoxidase indicated that these enzymes were catalyzed in the conversion of HP to HPPィイD1+ィエD1. Consequently, we conclude that HP and HPTP are converted to the neurotoxic pyridinium metabolite HPPィイD1+ィエD1 not by chemical processes but rather by peroxidase in brain.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] K. Igarashi: "The possible role of an active metabolite derived from the neuroleptic haloperidol"J. Toxicol. Toxin Rev.. 17. 27-38 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Matsubara: "Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter"Eur. J. Pharmacol.. 348. 77-84 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Igarashi: "Determination of 1-methy1-1, 2, 3, 4-tetrahydroisoquinoline in mouse brain after treatment with haloperidol by gas-"J. Chromatogr., B.. 731. 53-58 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Iwahashi: "CYP2D6 Hhal genotype and the neuroleptic malignant syndrome"Neuropsychobiology. 39. 33-37 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Inoue: "Species dependent differences in the monoamine oxidase A and B catalyzed oxidation of various C-4 subunited 1-methyl"J. Pharmacol. Exp. Ther.. 291. 856-864 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Igarashi: "The possible role of an active metabolite derived from the neuroleptic agent haloperidol"J. Toxicol. Toxin Rev.. 17. 27-38 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Matsubara: "Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter"Eur. J. Phaemacol.. 348. 77-84 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Igarashi: "Determination of 1-mathyl-1, 2, 3, 4-tetra-hydroisoquinoline in mouse brain after treatment with haloperidol by gas chromatography -selected ion monitoring"J. Chromatgr., B.. 731. 53-58 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Iwahashi: "CYP2D6 Hhal genotype and the neuroleptic malignant syndrome"Neuropsychobiology. 39. 33-37 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Inoue: "Species dependent differences in the monoamine oxidase A and B catalyzed oxidation of various C-4 substituted 1-methyl-4-phenyl-1, 2, 36-tetrahydropyridinyl derivatives"J. Pharmacol. Exp. Ther.. 291. 856-864 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Igarashi,K.: "Determination of I-methy-1,2,3,4-tetrahydroisoq noline in mouse brain after treatment with haloperidol by"J.Chromatogr.B.,. 731. 53-58 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Iwahashi,K.: "CYP2D Hhal genotype and the neuroleptic malignant syndrome"Neuropsychobiology. 39. 33-37 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Inoue H.: "Species dependent differences in the monoamine oxidase"J.Pharmacol.Exp.Ther.. 291. 856-864 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Castagnoli N.Jr.: "Enzyme-catalyzed bioactivation of cyclic tertiary amines to form potential neurotoxin"Pol.J.Pharmacol.. 51. 31-38 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] K.Igarashi: "The possible role of an active metabolite derived from the neuroleptic agent haloperidol in drug-induced Parkinsonism" J.Toxicol.Toxin Rev.17(1). 27-38 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] K.Matsubara: "Structural significance of azaheterocyslic amines related to Parkinson's disease for dopamine transporter" Eur.J.Pharmacol.348. 77-84 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 五十嵐一雄: "GC/SIMによる抗精神病薬投与動物における脳内在性パーキンソニズム防御物質I-MetiQ量の測定" Proc.Jap.Soc.Biomed.Mass Spectrom.23. 199-202 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 五十嵐一雄: "環状3級アミン類の代謝活性化と神経毒性" 日本医用マススペクトル学会サーキュラー. 44. 1-8 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi